BiotechTube

Comparator: placebo + Comparator: Estrace

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Postmenopause

Conditions

Postmenopause

Trial Timeline

May 1, 2008 → Oct 1, 2008

NCT ID
NCT00799708

About Comparator: placebo + Comparator: Estrace

Comparator: placebo + Comparator: Estrace is a phase 1 stage product being developed by Merck for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00799708. Target conditions include Postmenopause.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00799708Phase 1Completed

Competing Products

16 competing products in Postmenopause

See all competitors
ProductCompanyStageHype Score
bazedoxifene/conjugated estrogens combination tabletPfizerPhase 1
32
Bazedoxifene 10 mg/CE 0.625 mg + Bazedoxifene 20 mg/CE 0.625 mg + Bazedoxifene 40 mg/CE 0.625 mg + Bazedoxifene 10 mg/CE 0.45 mg + Bazedoxifene 20 mg/CE 0.45 mg + Bazedoxifene 40 mg/CE 0.45 mg + Raloxifene 60 mg + PlaceboPfizerPre-clinical
22
PremarinPfizerPre-clinical
22
Bazedoxifene and conjugated estrogensPfizerPhase 1
32
Premarin/MPA + Premarin/MPA + Provera 10 mgPfizerPhase 1
32
Bazedoxifene/conjugated estrogensPfizerPhase 1
32
PremarinPfizerPhase 1
32
bazedoxifene BZA-20PfizerPhase 3
76
Trimegestone + 17b EstradiolPfizerApproved
84
Premarin/MPA 0.45 mg/1.5 mgPfizerPhase 1
32
Conjugated Estrogen Cream (Premarin®)PfizerPre-clinical
22
Estradiol/DRSP (Angeliq, BAY86-4891)BayerApproved
82
0.25mg DRSP / 0.5mg E2 (BAY86-4891) + 0.5mg NETA / 1.0mg E2 (Activella)BayerPhase 3
74
E2/LNG oral (Wellnara, BAY86-5029)BayerPre-clinical
20
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) + SH K 00641 C - Medroxyprogesterone acetate / conjugated equine (Prempro TM)BayerPhase 2
49
Tibolone + Estradiol + Estradiol + Medroxy Progesterone AcetateOrganonApproved
80

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85